Sugar Editorial Picks
Jan 05, 2009 -
Often I feel we deserve medals for dealing with the cramps, crying spells, and other delights that accompany that time of the month. Some women even have to deal with heavy bleeding that lasts more than 10 days.
To control the bleeding without using birth control pills, women can now opt for a surgical procedure called endometrial ablation, which takes about 90 seconds.
- 45 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Menstrual Disorders
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
“No-Period” Pill Approved
In May 2007, the FDA approved Lybrel, the first birth control pill that completely eliminates monthly menstrual periods. Lybrel contains low doses of the estrogen estradiol and the progesterone levonorgestrol. The active pills are taken 365 days a year -- with no inactive pill breaks.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Lifestyle Changes
- Medications
- Conservative Surgery
- Hysterectomy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
Women with menstrual pain due to endometriosis have a new treatment option. In May 2007, the FDA approved Lybrel, a continuous-dose oral contraceptive that completely eliminates menstrual periods. Lybrel, which contains low doses of the estrogen estradiol and the progesterone levonorgestrol, is taken 365 days a year with active pills.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Lifestyle Changes
- Medications
- Surgery
- Other Procedures
- Hysterectomy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Uterine Artery Embolization Versus Standard Surgery
Many women with fibroids are considering a procedure called uterine artery embolization (UAE) as an alternative to standard surgery such as hysterectomy or myomectomy. A study published in 2007 in the New England Journal of Medicine compared these treatment approaches. The study suggested that UAE results in shorter hospital stay and faster recovery time, but a small percentage of women may later need repeat embolization or a hysterectomy.
- 0 Comments
Sep 03, 2008 -
Overview
- Definition
- Alternative Names
- Causes, incidence, and risk factors
- Symptoms
- Signs and tests
- Treatment
- Expectations (prognosis)
- Complications
- Calling your health care provider
- References
Illustrations
Normal uterine anatomy (cut section)
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Dysfunctional uterine bleeding (DUB) is abnormal bleeding from the vagina that is not due to a physical (anatomical) cause.
Alternative Names
Anovulatory bleeding; Bleeding - dysfunctional uterine; DUB; Abnormal uterine bleeding
Causes, incidence, and risk factors
DUB may be caused by an imbalance of hormones -- estrogen or progesterone.
Risk factors include:
- Emotional stress
- Excessive exercise
- Obesity
DUB occurs in women during their reproductive years (they have started their period but have not reached menopause).
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
Screening
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- What Causes It?
- Who's Most At Risk?
- What to Expect at Your Provider's Office
- Treatment Options
- Prognosis/Possible Complications
- Following Up
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Breast cancer is when a cancerous tumor occurs inside the breast. Each year more than 185,000 women are diagnosed with breast cancer. The incidence of this disease is rising in developed countries.
- 0 Comments
Sep 04, 2008 -
Overview
- Alternative Names
- Information
- References
Illustrations
Fibroid tumors
HEALTH GUIDE REFERENCE FROM A.D.A.M
Alternative Names
Treatment - fibroid tumors. Treatment - uterine leiomyoma
Information
Fibroid tumors are noncancerous growths (tumors) in the uterus. In most cases, treatment is not needed at all.
- 0 Comments